Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion recipient identification.

P Pagliaro1, P Rebulla

  • 1Centro Trasfusionale, Ospedale Carlo Poma, Mantua, Italy. simt.mantova@ospedalimantova.it

Vox Sanguinis
|August 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.

GeroScience·2020
Same author

Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src.

Acta physiologica (Oxford, England)·2017
Same author

Nanoprecipitated catestatin released from pharmacologically active microcarriers (PAMs) exerts pro-survival effects on MSC.

International journal of pharmaceutics·2016
Same author

Tissue engineering: chondrocyte cultures on type I collagen support. Cytohistological and immunohistochemical study.

Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology·2016
Same author

A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes.

Journal of cellular physiology·2014
Same author

Redox signalling and cardioprotection: translatability and mechanism.

British journal of pharmacology·2014
Same journal

In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

Vox sanguinis·2026
Same journal

Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

Vox sanguinis·2026
Same journal

Fibrinogen recovery in cryoprecipitate prepared from thawed plasma stored for 5 days post-thaw.

Vox sanguinis·2026
Same journal

Abstracts of the 39th International Congress of the ISBT, Kuala Lumpur, Malaysia, 20-24 June 2026.

Vox sanguinis·2026
Same journal

Development and improvement of Chinese Haemovigilance Network from 2018 to 2023.

Vox sanguinis·2026
Same journal

Marginal anaemia and perioperative transfusion in female patients undergoing cardiac surgery.

Vox sanguinis·2026
See all related articles

Patient identification errors in blood transfusions occur about once per 1000 events. New technologies like barcode bracelets and real-time data systems significantly reduce these dangerous mistransfusion errors.

Area of Science:

  • Medical safety
  • Haemovigilance
  • Transfusion medicine

Background:

  • Errors in the whole-blood transfusion chain are reported by haemovigilance systems.
  • Approximately 1 in 1000 transfusion events involve errors, with two-thirds stemming from incorrect patient identification at the bedside.

Purpose of the Study:

  • To highlight the frequency of errors in the blood transfusion chain.
  • To introduce and evaluate technologies designed to prevent mistransfusion errors, particularly those related to patient identification.

Main Methods:

  • Review of haemovigilance reports to determine error frequency.
  • Description of technological solutions: patient identification bracelets (barcode, RFID), secure blood bag access systems, and real-time data transfer via palm computers.
  • Analysis of studies demonstrating the effectiveness of these preventative systems.

Related Experiment Videos

Main Results:

  • Whole-blood transfusion errors occur at a rate of approximately 1 per 1000 events.
  • The majority of these errors (two-thirds) are linked to incorrect patient identification during bedside procedures.
  • Implemented technological tools have proven effective in preventing mistransfusions.

Conclusions:

  • Patient identification is a critical vulnerability in the blood transfusion chain.
  • Technological interventions, including barcode/RFID identification and real-time data systems, are effective in mitigating mistransfusion risks.
  • These systems enhance patient safety by reducing errors in blood administration.